Title: Analysis of treatment efficacy of cyclosporine A combined with human recombinant interleukin-11 in refractory immune thrombocytopenic purpura
Abstract:Objective To discuss the treatment efficacy of cyclosporine A( CSA) combined with human recombinant interleukin-11( IL-11) in refractory immune thrombocytopenic purpura. Methods All 37patients diagnos...Objective To discuss the treatment efficacy of cyclosporine A( CSA) combined with human recombinant interleukin-11( IL-11) in refractory immune thrombocytopenic purpura. Methods All 37patients diagnosed as refractory immune thrombocytopenic purpura were divided into observation group and control group. Observation group: IL-11 [30 μg /( kg · d) ] and CSA [5 mg /( kg · d) ] were added. Control group: only CSA [5 mg /( kg·d) ] was added. The observation time was six months. Results The effective rates were 91% and 63% in Observation group and Control group,respectively. The difference was significant( P 0. 05). Conclusion CSA combined with IL-11 had good treatment efficacy and security in refractory immune thrombocytopenic purpura.Read More
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot